Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of GSE and Xylitol (Xlear) in Symptoms and Time to PCR Negativisation of Patients With Acute COVID-19 Infection

NCT04854486 is registered in ClinicalTrials.gov with Larkin Community Hospital as lead sponsor.

NCT NCT04854486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04854486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of GSE and Xylitol (Xlear) in Symptoms and Time to PCR Negativisation of Patients With Acute COVID-19 Infection
Lead sponsor
Larkin Community Hospital
Phase
Phase 3
Overall status
Withdrawn
Start date
December 16, 2021
Completion date
November 16, 2022
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19